Converge Bio raised $5.5M in a seed round to scale its biotechnology-focused LLM product.

Nov 20, 2024•about 1 year ago

Amount Raised

$5.5 Million

Round Type

seed

WilmingtonMachine LearningArtificial IntelligenceBiotechnology

Description

Converge Bio has secured $5.5 million in a seed funding round to enhance its platform that helps companies effectively utilize biology-focused large language models. The funding will support the development and integration of their technology into pharmaceutical and biotech R&D processes.

Company Information

Company

Converge Bio

Location

Wilmington, Delaware, United States

About

Converge Bio is a biotechnology firm focused on integrating AI and machine learning into drug discovery and research processes. They specialize in developing tools that help companies effectively utilize biology-focused large language models (LLMs) by enhancing their data and providing insights into complex biological interactions. Their platform enables researchers to gain explainable results while generating new sequences to improve research outcomes.

Related People

3 contacts

Converge Bio raised $5.5M in a seed round to scale its biotechnology-focused LLM product.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information